跳至主要内容
临床试验/NCT03913156
NCT03913156已完成不适用

Feeding Patterns and Practices in Young Children With PKU During the First Two Years of Life: Acceptability and Efficacy of a New Protein Substitute

Nutricia Research3 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2010年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
46
试验地点
3
主要终点
Intake of energy and nutritients: Weaning

研究概览

简要总结

In this study the feeding patterns and practices at the introduction of a second stage phe-free protein substitute will be assessed in young children with PKU. This will be compared with the normal weaning process in healthy non-PKU age-matched children. In addition, tolerability and acceptability of the study product will be evaluated in a smaller group of subjects who have already been transferred onto a second stage protein substitute. The study is performed in 3 centers in the United Kingdom.

详细描述

Part 1:

For subjects with PKU, the study product will be incorporated in the diet as the second stage protein substitute until the subjects are 2 years of age.

The healthy non-PKU age-matched subjects will not have the study product incorporated in their diet in order to be able to compare the weaning experience and nutritional intake of PKU subjects with non-PKU subjects. The healthy subjects will also be part of the study until the subjects are 2 years of age.

Part 2:

All PKU subjects will take the study product for 7 days.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
— 至 5 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of PKU identified on screening during the newborn period and requiring a phenylalanine free protein substitute
  • •Subjects who are about to commence weaning and require a concentrated phe-free protein substitute to meet their total protein requirements and are aged between 4 and 10 months (Part 1)
  • •Subjects aged under 5 years who have already been fully transferred onto a concentrated phe-free protein substitute and are willing to try the study product for 7 days (Part 2)
  • •Written informed consent obtained from subject or parents / caregiver
  • •May or may not have commenced weaning solids (i.e. using normal foods)

排除标准

  • •Presence of serious concurrent illness
  • •Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
  • •Any child who has not commenced a second stage protein substitute and is over the age of 10 months
  • •Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • •Any children having taken antibiotics over the previous 2 weeks leading up to the study

研究组 & 干预措施

Part 1

Other

Part 1 of the study will recruit subjects who are about to be introduced to a concentrated phe-free protein substitute (i.e. second stage protein substitute) for the first time.

干预措施: B2970 Metabolic Texture Modified Protein Substitute (Other)

Part 2

Other

Part 2 of the study will recruit subjects who have already been introduced to a concentrated phe-free protein substitute (i.e. have already transferred from phe-free infant formula onto a second stage protein substitute). This group will be included to evaluate the acceptability of the study product in patients who have already moved onto a second stage protein substitute.

干预措施: B2970 Metabolic Texture Modified Protein Substitute (Other)

结局指标

主要结局

Intake of energy and nutritients: Weaning

时间窗: up to 2 years

Intakes of energy and nutrients from the weaning diet: descriptive information, intakes \[g/day\]

Intake of energy and nutritients: Study product

时间窗: up to 2 years

Intakes of energy and nutrients from the study product \[diet diary; #g product/day\]

Feeding practices and difficulties by questionnaire; position

时间窗: up to 2 years

Feeding practices entered by parents in diaries: the way the child has been fed will be assessed : categories \[sitting position e.g on lap, in chair etc\]

Feeding patterns- product intake

时间窗: up to 2 years

Actual intake of product and prescribed amount of product \[# sachets\] will be recorded as documented in diaries.

Feeding patterns - intake other than study product

时间窗: up to 2 years

Intakes of standard formulas / breast-milk and normal foods \[mL\] or \[g/day\] and \[frequency\] of breastfeeding, as documented in diaries.

Feeding practices and difficulties by questionnaire; self feeding

时间窗: up to 2 years

Feeding practices entered by parents in diaries; the way the child has been fed will be assessed : \[self-feeding; parent feeding\]; \[type of self feeding: bottle, finger; spoon, fork\]

Occurence of Adverse Events [ Safety and tolerability]

时间窗: up to 2 years

Occurence of Adverse Events

Gastro-Intestinal symptoms

时间窗: up to 2 years

Occurence of GI symptoms \[yes/no\] for: * Mouth Ulcers * Tummy upset * Harder poos * Constipation * Softer poos * Vomiting * Colic * Other (free entry)

Product Acceptability yes/no

时间窗: up to 2 years

Acceptability questions \[yes/no\] for: * Refuses more than takes * Refuses as much as takes * Takes more than refuses * Spits out product * Puts spoon away * Holds in mouth but won't swallow * Closes mouth on feeding * Cries at beginning of feed * Cries at end of feed * Deliberately spills feed * Turns head away * Other (free entry)

Blood Phenylalanine control: Phe levels

时间窗: up to 2 years

Phe levels \[umol/L\]

Blood Tyrosine levels

时间窗: up to 2 years

Tyrosine levels \[umol/L\]

Anthropometry: weight

时间窗: up to 2 years

Weight \[g\]

Anthropometry: length

时间窗: up to 2 years

Length \[cm\]

次要结局

  • Anxiety levels of parents - Beck's Anxiety inventory(up to 2 years)
  • Weaning per group (with our without protein substitute) - descriptive(up to 2 years)
  • Coping mechanisms of parents by questionnaire(up to 2 years)
  • Parent experience of Feeding via questionnaire(up to 2 years)

研究者

发起方
Nutricia Research
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验